Shares of Cell MedX Corp. (OTCMKTS:CMXC – Get Free Report) passed below its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $0.41 and traded as low as $0.22. Cell MedX shares last traded at $0.30, with a volume of 204,286 shares changing hands.
Cell MedX Trading Down 36.5 %
The stock’s fifty day moving average price is $0.41 and its 200 day moving average price is $0.26.
Cell MedX Company Profile
Cell MedX Corp., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson’s disease, high blood pressure, neuropathy, and kidney functions in the United States. The company develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual.
Recommended Stories
- Five stocks we like better than Cell MedX
- ESG Stocks, What Investors Should Know
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- 3 Tickers Leading a Meme Stock Revival
- 3 Must-Own Stocks to Build Wealth This Decade
- Transportation Stocks Investing
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Receive News & Ratings for Cell MedX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cell MedX and related companies with MarketBeat.com's FREE daily email newsletter.
